Actualités

UiPath (PATH) stock is in focus after the company signed a three year contract to build an AI driven pricing platform for UK online retailer The Very Group, adding fresh context to its automation business. See our latest analysis for UiPath. The latest Very Group contract and earlier news around buybacks and profitability come as UiPath trades at US$11.95, with a 30 day share price return of 10.75% but a 5 year total shareholder return that has declined about 81%. Recent momentum therefore...

Earlier this week, UiPath reported its first-ever quarterly GAAP operating profit and highlighted that its AI agentic products are progressing from pilot to production, while also maintaining a share repurchase program with about US$414 million still available. The company also announced a three-year agreement to build an AI-driven pricing platform for UK online retailer The Very Group, underscoring how its automation and AI tools are being applied to complex, margin-sensitive retail...

UiPath stock is trading near US$11.95 after a long stretch of weak returns, yet the valuation work suggests the market may be pricing it below what its cash flows could justify, with both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples pointing to an undervalued profile. Over the last 5 years, UiPath has delivered a share price decline of about 81.0%, which means long term holders have seen substantial value eroded even as the current valuation screens as...

The companies are helping drive increased automation in industrial applications.

PATH's six-month pullback comes as AI adoption, enterprise customer growth and profitability improve, creating a more attractive entry point.

In the closing of the recent trading day, UiPath (PATH) stood at $11.68, denoting a -1.02% move from the preceding trading day.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

When a company’s business grows but its stock price stagnates, investors are left with a difficult question: is the market seeing a problem, or just looking the other way.

PATH's pullback has lowered its valuation as improving profitability, ARR growth and an upbeat outlook strengthen the long-term investment case.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

UiPath’s agentic automation push is raising the stakes for its next report, where investors will look for proof that new workflow tools are lifting ARR, retention, and margins.

PATH's Maestro Case launch expands its reach into complex enterprise workflows, deepening its push beyond traditional automation.

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how automation software stocks fared in Q1, starting with UiPath (NYSE:PATH).

If you are looking at UiPath and wondering whether the current share price reflects its true worth, this article focuses squarely on what the numbers say about value. The stock last closed at US$10.31, with returns of 0.8% over the past week, a decline of 5.7% over the past month, a decline of 35.1% year to date, and a decline of 17.3% over the past year, which may change how investors think about both upside potential and risk. Over the last three years UiPath has recorded a decline of...

PATH's AI orchestration push and growing enterprise adoption make it a more compelling buy over NU despite Nubank's strong fintech growth.

Earlier this month, UiPath launched Maestro Case, an AI-native case management capability within its Maestro orchestration platform, aimed at helping enterprises handle complex, long-running, exception-heavy workflows across hybrid environments with greater control, visibility, and speed. The product is already generating attention for materially cutting case handling times and increasing automation in areas like dispute resolution and KYC, underlining how agentic automation could reshape...

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

UiPath Inc. (NYSE:PATH) is one of the 10 best robotics and automation stocks to invest in. On June 4, UiPath Inc. (NYSE:PATH) announced that One NZ elevated the standards for corporate service delivery throughout ANZ with UiPath MaestroTM. Using a cloud-native orchestration platform that integrates AI agents, automation, and human collaboration into straightforward, end-to-end business […]

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

UiPath is giving enterprises more ways to coordinate AI agents, robots, and people, with the next readout focused on whether agentic automation demand can lift recurring revenue and customer expansion.

UiPath Inc. (NYSE:PATH) is one of the best AI software stocks to buy according to hedge funds. UiPath Inc. (NYSE:PATH) announced on June 16, Maestro Case, which is a new AI-native UiPath agentic case management capability available as part of the UiPath Maestro™ business orchestration capabilities. It further stated that Maestro Case “extends governed orchestration and […]

PATH is seeing agentic AI move from pilot projects to production deployments, strengthening demand for its automation platform.

From commerce to culture, software is digitizing every aspect of our lives. In the past, the undeniable tailwinds fueling SaaS companies led to lofty valuation multiples that made it easier to raise capital. But this was a double-edged sword as the high prices exposed them to big drawdowns, and unfortunately, the industry has tumbled by 9.8% over the last six months. This performance is a noticeable divergence from the S&P 500’s 8.4% return.

The mean of analysts' price targets for UiPath (PATH) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

UiPath overview and recent share performance UiPath (PATH) has stayed in focus for investors after a period of mixed share performance, with the stock down over the past year and past 3 months but slightly higher over the past month. See our latest analysis for UiPath. With the share price at $10.55, UiPath has seen pressure this year, with the year to date share price return down 33.56% and the 1 year total shareholder return down 13.81%, pointing to fading momentum despite a modest 30 day...

Is PATH a good stock to buy? We came across a bullish thesis on UiPath, Inc. on Montana Insights’s Substack by Montana Matos. In this article, we will summarize the bulls’ thesis on PATH. UiPath, Inc.’s share was trading at $11.17 as of June 8th. PATH’s trailing and forward P/E were 18.73 and 14.14 respectively according to […]

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

PATH is growing its base of high-value customers, signaling deeper enterprise adoption of its automation and AI platform.

UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.